Læknablaðið - 15.05.1996, Blaðsíða 14

370
LÆKNABLAÐIÐ 1996; 82
hárrar tíðni magakrabbameins. Áhugavert
væri að skoða faraldsfræði H. pylori sýkinga
nánar með tilliti til landfræðilegrar útbreiðslu.
Þakkarorð
Þakkir til þeirra fjölmörgu sem aðstoðuðu
við söfnun blóðsýnanna.
HEIMILDIR
1. Marshall BJ, Warren JR. Unidentified curved bacilli in
the stomach of patients with gastritis and peptic ulcer-
ation. Lancet 1984; i: 1311-5.
2. Jóhannsson JH, Harðardóttir H, Sigvaldadóttir E,
Kristjánsdóttir S, Þjóðleifsson B, Oddsson E, et al.
Campylobacter pylori í magaslímhúð. Framvirk rann-
sókn á algengi C. pylori í magaslímhúð sjúklinga með
einkenni um bólgu eða sár í maga. Læknablaðið 1989;
75: 191-6.
3. Oddsson E, Guðjonsson H, Theodors Á, Björnsson S,
Gunnlaugsson Ó, Gormsen M, et al. De-Nol or De-Nol
+ Metronidazole in the treatment of Helicobacter pylori
positive patients with non ulcer dyspepsia: symptomatic
response and eradication rate. Gastroenterology 1992;
102/Suppl. 4: A137.
4. Moss S, Calam J. Helicobacterpylori and peptic ulcers.
The present position. Gut 1992; 33: 289-91.
5. Graham DY. Campylobacter pylori and peptic ulcer
disease. Gastroenterology 1989; 96: 615-25.
6. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D.
Helicobacter pylori and gastric carcinoma. Serum anti-
body prevalence in population with contrasting cancer
riskt. Cancer 1990; 66: 2569-74.
7. The Eurogast Study Group. An international associ-
ation between Helicobacter pylori infection and gastric
cancer. Lancet 1993; 341: 1359-62.
8. Mc-Nulty CAM, Wise R. Rapid diagnosis of Campylo-
bacter pyloridis gastritis. Lancet 1986; i: 387.
9. Lelwala-Guruge J, Schaién C, Nilsson I, Ljungh Á,
Tyszkiewicz T, Wikander M. Detection of antibodies to
Helicobacter pylori cell surface antigens. Scand J Infect
Dis 1990; 22: 457-65.
10. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Apple-
man D, Perez-Perez GI, et al. Prevalence of Heiicobac-
ter pylori infection and histologic gastritis in asympto-
matic persons. N Engl J Med 1989; 321: 1562-6.
11. Megraud F, Brassens-Rabbe MP, Denis F, Belbouri A,
Hoa DQ. Seroepidemiology of Campylobacter pylori
infection in various populations. J Clin Microbiol 1989;
27: 1870-3.
12. Kosunen TV, Hook J, Rautelen HI, Myllya G. Age
dependent increase of Campylobacter pylori antibodies
in blood donors. Scand J Gastroenterol 1989; 24:110-4.
13. Mitchell HM, Lee A, Berkowicz J, Borody T. The use of
serology to diagnose active Campylobacter pylori in-
fection. Med J Aust 1988: 149: 604-9.
14. Perez-Perez GI, TaylorDN, Bodhidatta L, Wongsricha-
nalai J, Baze WB, Dunn BE, et al. Seroprevalence of
Campylobacter pylori infections in Thailand. J Infect Dis
1990; 161: 1237-41.
15. Graham DY, Klein PD, Opekum AR, Boutton TW.
Effect of age on the frequency of active Campylobacter
pylori infection diagnosed by the urea breath test on
normal subjects and patients with peptic ulcer disease. J
Infect Dis 1988; 157: 773-80.
16. Kekki M, Siurala M, Varis K, Sipponen P, Sistonen P,
Nevanlinna HR. Chronic gastritis: dynamic and clinical
aspects. ScandJ Gastroenteroll987;22/Suppl. 141:1-28.
17. Kosunen TV, Seppala K, Sarna S, Sipponen P. Diag-
nostic value of decreasing IgG, IgA, and IgM antibody
titers after eradication of Helicobacter pylori. Lancet
1992; 339: 893-5.
18. Briem H, Weiland O, Friðriksson I, Berg R. Prevalence
of antibody to hepatitis in Iceland in relation to age, sex,
and number of motified cases of hepatitis. Am J Epide-
miol 1982; 116: 451-5.
19. Correa P. A human model of gastric carcinogenesis.
Cancer Res 1988; 48: 3554-60.
20. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey
AR, Wald N, et al. Association between infection with
Helicobacter pylori and risk of gastric cancer. Br Med J
1991; 302: 1302-5
21. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y,
Vogelman JH, Orentreich N, et al. Helicobacter pylori
infection and the risk of gastric carcinoma. N Engl J Med
1991; 325: 1127-31.
22. Nomura A, Stemmermann GN, Chyou PH, Kate I,
Perez-Perez GI, Blaser MJ. Helicobacter pylori infec-
tion and gastric carcinoma among Japanese Americans
in Hawaii. N Engl J Med 1991; 325: 1132-6.
23. Forman D, Sitas F, Newell DG, Stacey AR, Boreham J,
Peto R, et al. Geographic association of Helicobacter
pylori antibody prevalence and gastric cancer mortality
in rural China. Int J Cancer 1990; 46: 608-11.
24. Fox JG, Correa P, Taylor NS, Zavala D, Fontham E,
Janney F, et al. Campylobacterpyloriassociated gastritis
and immune response in a population at an increased
risk of gastric carcinoma. Am J Gastroenterol 1989; 84:
775-81.
25. Gastrointestinal Physiology Working Group. Helicobac-
terpylori and gastritis in Peruvian patients: relationship
to socioeconomic level, age and sex. Am J Gastroente-
rol 1990; 85: 819-23.
26. Axon ATR. The ascorbic acid story. In: Hunt RH,
Tytgat GNJ, eds. Helicobacterpylori: basic mechanisms
to clinical cure. Dordrect/Boston/London: Kluwer Aca-
demic Publishers, 1994.
27. Dungal N. The special problem of stomach cancer in
Iceland. JAMA 1961; 178: 789-98.
28. Sigurjónsson J. Geographical variationin mortality from
cancer in Iceland, with particular reference to stomach
cancer. J Nat Cancer Inst 1966; 37: 337-46.
29. Dungal N, Sigurjonsson J. Gastric cancer and diet. A
pilot study on dietary habits in two districts differing
markedly in respect of mortality from gastric cancer. Br
J Cancer 1967; 21: 270-6.
30. Perez-Perez GI, Dworken BM, Chodos JE, Blaser MJ.
Campylobacterpylori antibodies in humans. Ann Intem
Med 1988; 109: 11-7.
31. De Giacomo C, Fiocca R, Villani L, Lisato L, Licardi G,
Diegoli N, et al. Helicobacter pylori infection and chron-
ic gastritis: clinical, serological and histologic correla-
tions in children treated with amoxicillin and colloidal
bismut subcitrate. J Pediatr Gastroenterol Nutr 1990; 11:
310-6.
32. Lelwala-Guruge J. Nilsson I, Ljungh Á, Wadström T.
Cell surface proteins of Helicobacter pylori as antigens in
an ELISA and a comparison with three commercial
ELISA. Scand J Infect Dis 1992; 24: 457-65.